137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) pr... von Iwata, H., Rubovszky, G., Loibl, S., Ciruelos, E., Campone, M., Juric, D., Rugo, H., Mayer, I., Conte, P.F., Kaufman, B., Inoue, K., Tesch, H., Li, Y-S., Mingorance, I.D., Ryvo, L., Iwase, H., Longin, A-S., Mills, D., Wilke, C., André, F.

Volltext

137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR1), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) pr... von Iwata, H., Rubovszky, G., Loibl, S., Ciruelos, E., Campone, M., Juric, D., Rugo, H., Mayer, I., Conte, P.F., Kaufman, B., Inoue, K., Tesch, H., Li, Y.-S., Mingorance, I.D., Ryvo, L., Iwase, H., Longin, A.-S., Mills, D., Wilke, C., Andre, F.

Volltext